Ingenovis Health Inc. has upsized its proposed incremental first-lien term loan by $50 million, to $150 million, according to sources. Recommitments are due today by 5 p.m. ET.

The add-on is offered at 99.75 and will be fungible with the existing covenant-lite first-lien term loan due March 2028 that is priced at L+375, with a 0.75% Libor floor. At talk, the yield to maturity is around 4.63%. There will be no call protection.

Citizens and UBS are joint lead arrangers on the deal. Citizens is administrative agent.

Proceeds will be used to finance an acquisition.

The term loan totaled $525 million when it was originally placed in March to back the buyout of Trustaff Management Inc. as well as Fastaff Travel Nursing and U.S. Nursing Corp. by Cornell Capital and Trilantic North America. The borrower was previously CCRR Parent Inc.

Corporate and facility ratings are B/B2, with stable outlooks, and the recovery rating on the loan is 3 from S&P Global Ratings.

Ingenovis provides traditional travel nurse, rapid response and strike preparedness staffing services to a broad base of healthcare facilities, including hospitals, medical centers and senior living facilities in the U.S.